Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jun 23:13:264.
doi: 10.25259/SNI_117_2022. eCollection 2022.

Cerebellopontine angle metastasis of a neuroendocrine tumor mimicking vestibular schwannoma: A case report

Affiliations
Case Reports

Cerebellopontine angle metastasis of a neuroendocrine tumor mimicking vestibular schwannoma: A case report

Shuhei Yamada et al. Surg Neurol Int. .

Abstract

Background: Neuroendocrine tumors (NETs) are uncommon neoplasms arising from neuroendocrine cells and are rarely associated with intracranial metastases.

Case description: We discuss the case of a 74-year-old woman with a right CPA tumor. She had a history of retroperitoneal NET, but was diagnosed with vestibular schwannoma due to a right-sided hearing loss and a right CPA tumor along the VII and VIII nerves. After a 3-year follow-up, she presented with repetitive vomiting, a 1-month history of gait instability, and a 3-month history of general fatigue. Brain imaging revealed tumor growth and edematous changes in the right cerebellum. She underwent retrosigmoid craniotomy and partial resection. Histopathological examination revealed metastatic NET. She underwent stereotactic radiosurgery for residual lesion and, at 11 months of follow-up, the lesion was confirmed to have shrunk on magnetic resonance imaging (MRI).

Conclusion: This is the first case to report the natural course of cerebellopontine metastasis of a NET. The differential diagnosis of CPA tumors is diverse, and, in our case, we suspected a vestibular schwannoma because of the typical symptoms and imaging features. However, the tumor grew relatively faster than expected and showed intratumoral hemorrhage during the 3-year follow-up. Therefore, in patients with a history of a NET, a careful follow-up is advisable even for lesions highly suspected to be another benign tumor on MRI. Careful follow-up imaging and appropriate treatment strategies were useful to manage the brain metastasis. Although NETs metastasizing to the CPA are extremely rare, this possibility should be considered when patients with NETs have intracranial lesions.

Keywords: Brain metastasis; Case report; Cerebellopontine angle tumor; Neuroendocrine tumor; Neuroendocrine tumors; Vestibular schwannoma.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1:
Figure 1:
Contrast-enhanced magnetic resonance imaging (CE-MRI) findings of the cerebellopontine angle lesion. (a) Images taken on the first consultation showed a suspicious lesion of about 12 mm in size, resembling a vestibular schwannoma, at the right cerebellopontine angle. (b) CE-MRI images 2 years after the first consultation (13 months before admission) showed no change in the tumor size. (c) CE-MRI images taken 7 months before admission showed an intratumoral cyst and tumor growth to 20 mm. (d) CE-MRI taken 1 month before admission showed intratumoral hemorrhage, edematous changes in the right cerebellum, and tumor growth to 27 mm.
Figure 2:
Figure 2:
Imaging findings on the day of admission. Computed tomography scan (a), contrast-enhanced magnetic resonance imaging (CE-MRI) (b), and fluid-attenuated inversion recovery (c) images on the day of admission showing the tumor (arrow), hemorrhage (arrowhead), and extensive edematous changes in the right cerebellum. CE-MRI (d) showed the enlargement of lateral ventricles.
Figure 3:
Figure 3:
Histological findings indicating metastatic neuroendocrine tumors. Hematoxylin and eosin staining showed monotonous tumor cells with round nuclei and eosinophilic cytoplasm arranged in nested or trabecular pattern (a). Immunohistochemically, tumor cells were positive for cytokeratin (b), synaptophysin (c), and CD56 (d), although they were negative for chromogranin A (e). Ki-67 labeling index was 5.7% (f).
Figure 4:
Figure 4:
Postoperative imaging findings. Contrast-enhanced magnetic resonance imaging on the next day after the surgery (a and b) showing partial resection of the tumor. T1-weighted MRI 11 months after surgery (c and d) showing a reduction in the size of the residual lesions.

Similar articles

References

    1. Bhojwani N, Huang J, Gupta A, Badve C, Cohen ML, Wolansky LJ. Rectal carcinoid tumor metastasis to a skull base meningioma. Neuroradiol J. 2016;29:49–51. - PMC - PubMed
    1. Brown PD, Ballman KV, Cerhan JH, Anderson SK, Carrero XW, Whitton AC, et al. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): A multicentre, randomised, controlled, phase 3 trial. Lancet Oncol. 2017;18:1049–60. - PMC - PubMed
    1. Cao F, Sada DM, Lai S, Sada YH. Stereotactic radiosurgery for carcinoid brain metastasis: A case report. Cureus. 2019;11:e5509. - PMC - PubMed
    1. Harrison CJ, Martin SC, Hofer M, Corkill R, Jeyaretna DS, Griffiths SJ. More than meets the MRI: Case report of a carcinoid tumour metastasis mimicking a meningioma. Br J Neurosurg. 2019;33:229–30. - PubMed
    1. Hlatky R, Suki D, Sawaya R. Carcinoid metastasis to the brain. Cancer. 2004;101:2605–13. - PubMed

Publication types

LinkOut - more resources